vimarsana.com

Multiples Alternate Asset Management Private News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CCI approves acquisition of additional Series E compulsorily convertible preference shares of Acko Technology & Services Private Limited

The List Of 23 Indian Ecommerce Unicorns

Sanctum Wealth Raises INR 78 Cr From The Xander Group

Sanctum Wealth Raises INR 78 Cr From The Xander Group
inc42.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inc42.com Daily Mail and Mail on Sunday newspapers.

Cyril Amarchand Mangaldas advises Zydus Cadila on sale of its India-focused Animal Healthcare Business for INR 2921 crores

New Delhi/ Mumbai (Maharashtra) [India], May14 (NewsVoir): Cyril Amarchand Mangaldas advised Zydus Cadila on sale of its India-focussed animal healthcare business to Zenex Animal Health India Private Limited (Zenex), which is a special purpose vehicle set up by Multiples led consortium of investors, for INR 2921 crores (~US USD 398 million) on a cash-free debt-free basis. As part of the Transaction, Cadila Healthcare Limited s animal healthcare business subsidiary Zydus Animal Health and Investments Limited has entered into a Business Transfer Agreement, dated May 12, 2021, with Zenex for sale of its Animal Healthcare Established Markets Undertaking to Zenex, as a going concern, on slum sale basis.

Zydus to sell animal healthcare business to Zenex for ₹2,921 crore

Zydus to sell animal healthcare business to Zenex for ₹2,921 crore May 12, 2021 × Inks agreement to sell businesses in India and some other countries by way of a slump sale   Cadila Healthcare Limited (Zydus Cadila) on Wednesday said its wholly-owned Zydus Animal Health and Investment Limited (ZAHL) has entered into a Business Transfer Agreement with Zenex Animal Health India Private Limited to sell itsanimal healthcare business. Zydus will sell the Animal Healthcare Established Markets Undertaking - the animal healthcare business in India and certain other countries - by way of a slump sale- for an estimated consideration amount of ₹2,921 crore, subject to certain closing date adjustments in terms of the Definitive Agreements, the company said in a regulatory filing.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.